Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for prevention of amphotericin B-related nephrotoxicity
IRCT2012110411364N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of Intralipid 10% and amphotericin b in mycoses (2 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
Intralipid 10%amphotericin b
03
Conditions
mycoses
Beyond the preview
Go deeper on IRCT2012110411364N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012110411364N1.